病例控制和基因组流行病学特征SARS-CoV-2突破性感染在三角洲到Omicron过渡期间
Erin Yuan1, Chelsea L Hansen2,3, Sana Tamim4
1Harvard University, Cambridge, Massachusetts, USA.
mBio
|January 8, 2026
概括
接种疫苗显著减少了SARS-CoV-2突破性感染的严重结果,即使是Omicron变种. 旅行的增加导致了更加多样化的Omicron引入,强调了持续疫苗接种和基因组监测的必要性.
科学领域:
- * 传染病 传染病
- * 病毒学 病毒学
- * 流行病学 流行病学
背景情况:
- * 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 变种,如德尔塔和奥米克朗,导致广泛的突破性感染 (BI).
- * 墨西哥的尤卡坦地区是多种疫苗的旅游枢纽,在三角洲-奥米克朗过渡期间提供了一个独特的环境来研究BI.
研究的目的:
- *以鉴定尤卡坦地区的SARS-CoV-2BI,评估疾病严重程度,症状和传播动态.
- *提供证据支持针对新兴变种的疫苗接种活动.
- *将放松的公共卫生限制与病毒引入和Omicron浪潮联系起来.
主要方法:
- *病例控制研究 (n=13,325) 通过逻辑回归比较BI (n=5,183) 与未接种疫苗的感染 (n=8,142).
- *205个BI序列的植物动力学建模,在全球上下文化 (n=1,152),以重建进化历史和传播路径.
- *在三角洲病毒转变为奥米克朗病毒期间 (2021年9月至2022年1月) 流行病学和基因组数据的分析.
主要成果:
- * 接种疫苗显著减少了BI中的住院 (OR=0.38) 和死亡 (OR=0.45) 与未接种疫苗的感染相比.
- * 欧米克朗感染的严重程度低于型 (住院OR=0.60;死亡OR=0.33) 且症状不同.
- *植物动力学揭示了许多引入;Omicron BIs的起源更为多样化,与放松的旅行限制有关.
结论:
- * 疫苗在三角形和欧米克朗波期间保持了对严重结局的保护.
- * Omicron的增强传播能力和增加的引入突出了与放宽公共卫生措施相关的风险.
- * 调查结果强调了持续接种疫苗,基因组监测,适应性政策和跨境合作对疫情准备的重要性.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Steps in Outbreak Investigation
485
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
485
Viral Mutations
39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Causality in Epidemiology
1.5K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.5K
Introduction to Epidemiology
1.6K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.6K
Viral Recombination
24.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.9K


